The pharmaceutical landscape for glucose is changing, and these patches represent a potential advance. Unlike subcutaneous injections, this approach offers a simpler way to deliver GLP-1 medications. These transdermal systems gradually release the treatment through the epidermis offering a even dose of the active agent, which can enhance glucose… Read More